One aspect relates to a catheter system, a use of such catheter system and a manufacturing method for such catheter system. The catheter system includes an at least partially flexible catheter body, at least a ring electrode, and at least a strain gauge. The ring electrode surrounds at least a portion of the flexible catheter body. The strain gauge is allocated to the ring electrode and the strain gauge is configured to measure a deformation of the flexible catheter body at a position allocated to the ring electrode to detect a contact between the ring electrode and tissue.

An implantable medical device comprises an electronic functional device for performing a function of said implantable medical device, said electronic functional device having an operational state for performing said function and a switched-off state. A wake-up device serves for transferring said functional device from said switched-off state to said operational state. The wake-up device comprises a first timer circuit for repeatedly transferring the functional device to the operational state according to a predetermined first timing scheme, a detection device for detecting a signal from a signal source external to the implantable medical device, and a second timer circuit for repeatedly switching the detection device to a reception state according to a second timing scheme.

The present disclosure relates to implantable neuromodulation devices and methods of fabrication, and in particular to a separable high density connectors for implantable neuromodulation devices. Particularly, aspects of the present disclosure are directed to a medical device comprising an electronics module and a header for connecting the electronics module to a lead assembly. The header includes: a housing that includes (i) a cavity having a central axis or plane and an internal surface, and (ii) an opening aligned with the central axis or plane of the cavity, an array of retractable contacts extending from the internal surface towards the central axis or plane of the cavity, and an array of connection terminals on the housing, where each connection terminal of the array of connection terminals is: (i) electrically connected to the electronics module, and (ii) electrically connectable to a retractable contact of the array of retractable contacts.

Some embodiments include a dipolar antenna system to electrically power an implantable miniature device and/or to stimulate bioelectrically excitable tissue. Other related systems and methods are also disclosed.

A control module for an electrical stimulation system includes a sealed electronics housing; an electronic subassembly disposed within the electronics housing; one or more connector assemblies coupled to the electronic subassembly; and a rechargeable battery disposed external to the electronics housing. The one or more connector assemblies are configured to receive a lead. The rechargeable battery includes a positive electrode, a negative electrode, and a single battery case attached directly to the sealed electronics housing and forming a sealed cavity that encapsulates both the positive electrode and the negative electrode. The battery case is electrically isolated from each of the positive electrode and the battery electrode.

An example of a system for delivering neurostimulation may include a programming control circuit and a stimulation control circuit. The programming control circuit may be configured to generate stimulation parameters controlling delivery of the neurostimulation according to a stimulation configuration. The stimulation control circuit may be configured to specify the stimulation configuration, and may include volume definition circuitry and stimulation configuration circuitry. The volume definition circuitry may be configured to determine one or more test volumes, determine a clinical effect resulting from the one or more test volumes each being activated by the neurostimulation, and determine a target volume using the determined clinical effect. The stimulation configuration circuitry may be configured to generate the specified stimulation configuration for activating the target volume.

In some examples, a medical device system includes a first implantable medical device. The first implantable medical device (IMD) may comprise circuitry configured to at least one of deliver a therapy to a patient or sense a physiological signal from the patient; generate stimulation deliverable to a patient; a first rechargeable power source; and a secondary coil coupled to the first rechargeable power source, the secondary coil configured to charge the first rechargeable power source via inductive coupling with a primary coil of an external charging device. The medical device system may comprise processing circuitry configured to control charging of the first rechargeable power source based on a charge state of a second rechargeable power source of a second IMD.

An implantable medical device (IMD), includes a processor for controlling the IMD; circuitry for providing therapeutic or diagnostic medical operations for a patient; wireless communication circuitry for conducting wireless communications; a non-rechargeable battery; and device power control circuitry. The device power control circuitry includes at least one capacitor; charging control circuitry for switching between charging the at least one capacitor using the non-rechargeable battery and discharging the at least one capacitor to provide power for device operations. The IMD is configured to maintain a count related to a number of times of discharge of the at least one capacitor to provide an end-of-life estimation for the non-rechargeable battery.

Antibacterial coatings and methods of making the antibacterial coatings are described herein. A first branched polyethylenimine (BPEI) layer is formed and a first glyoxal layer is formed on a surface of the BPEI layer. The first BPEI layer and the first glyoxal layer are cured to form a crosslinked BPEI coating. The first BPEI layer can be modified with superhydrophobic moieties, superhydrophilic moieties, or negatively charged moieties to increase the antifouling characteristics of the coating. The first BPEI layer can be modified with contact-killing bactericidal moieties to increase the bactericidal characteristics of the coating.

In general, devices, systems, and methods for control of one visualization with another are provided.